| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0099 | 0.9 |